drugset / Trial / NCT01070043

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

NCT01070043

Phase 4 Completed 60 enrolled Novartis
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study was to assess efficacy and safety of fixed dose combination of 5 mg amlodipine/80 mg valsartan compared to 160 mg valsartan monotherapy in lowering blood pressure in Taiwanese patients.

Timeline

Start
2009-06
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Valsartan Small molecule 80 mg Oral
Subject Valsartan Small molecule 160 mg Oral

Indications